Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus

NCT07629557 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratoconus

Interventions

DRUG: Riboflavin Ophthalmic Solutions
DEVICE: UV-A Irradiation System

Sponsor

Glaukos Corporation